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DOI 10.1016/j.ccr.2011.08.011SUMMARYPostnatal oligodendrocyte progenitor cells (OPC) self-renew, generate mature oligodendrocytes, and are a
cellular origin of oligodendrogliomas. We show that the proteoglycan NG2 segregates asymmetrically during
mitosis to generate OPC cells of distinct fate. NG2 is required for asymmetric segregation of EGFR to the
NG2+ progeny, which consequently activates EGFR and undergoes EGF-dependent proliferation and self-
renewal. In contrast, the NG2 progeny differentiates. In a mouse model, decreased NG2 asymmetry coin-
cides with premalignant, abnormal self-renewal rather than differentiation and with tumor-initiating potential.
Asymmetric division of human NG2+ cells is prevalent in non-neoplastic tissue but is decreased in oligoden-
drogliomas. Regulators of asymmetric cell division are misexpressed in low-grade oligodendrogliomas. Our
results identify loss of asymmetric division associated with the neoplastic transformation of OPC.INTRODUCTION
Studies in mouse models have shown that oligodendrocyte
progenitor cells (OPC) carrying tumor-initiating mutations are
a cellular origin of oligodendroglioma, a progressive primary
malignancy of the adult central nervous system andmajor glioma
class (Lindberg et al., 2009; Persson et al., 2010; Weiss et al.,Significance
Defects accompanying the neoplastic transformation of NG2+
stood. We demonstrate that normal OPC undergo asymmetri
We provide mechanistic insights explaining how NG2 partici
a one-to-one ratio of self-renewing and differentiating cells. We
in human NG2+ oligodendroglioma cells and in aberrantly self-
we identify as oligodendroglioma precursors, due to their tumo
divisions maintain homeostasis in the postnatal oligodendrocy
distinguishes NG2+ glioma precursors and glioma cells from n
328 Cancer Cell 20, 328–340, September 13, 2011 ª2011 Elsevier In2003). Glioma cells expressing the OPC marker NG2 have high
tumor-initiating potential (Persson et al., 2010). Moreover, differ-
entiation-defective NG2+ cells are the predominant cell type in
human low-grade gliomas (Brianc¸on-Marjollet et al., 2010) and
in highly invasive rodent gliomas (Assanah et al., 2006). These
observations indicate that NG2+ OPC are a cellular origin of oli-
godendrogliomas and that they persist in tumors and provideoligodendrocyte progenitor cells (OPC) were poorly under-
c divisions by asymmetrically segregating NG2 and EGFR.
pates in a cell fate switch and NG2 asymmetry generates
unravel loss of asymmetric division at premalignant stages
renewing, differentiation-defective murine NG2+ OPC, which
r-initiating potential. Our data suggest that asymmetric cell




Asymmetry Defects in Glioma Precursorslong-term growth (Pei and Wechsler-Reya, 2010). Whether
premalignant NG2+ OPC carry defects in self-renewal and differ-
entiation, similar to premalignant neural stem cells in a mouse
model for astrocytoma (Alcantara Llaguno et al., 2009) and to
the brain-tumor-initiating cells in human gliomas (Galli et al.,
2004; Hemmati et al., 2003; Singh et al., 2003), is still unclear.
Identifying these defects in OPC and unraveling their underlying
causes is expected to fill a gap in our understanding of themech-
anisms by which normal OPC turn into glioma cells.
Stem and progenitor cells across species undergo asym-
metric divisions to simultaneously self-renew and generate
differentiating cells (Knoblich, 2010). Polarity proteins provide
a cue for cell fate determinants to localize asymmetrically and
for the mitotic spindle to align along the polarity axis. This coor-
dinated localization pattern ensures that cell fate determinants
partition unequally during cytokinesis and that the two daughter
cells acquire distinct fate. In the adult rodent brain, OPC ex-
pressing the chondroitin sulfate proteoglycan NG2 are the
largest proliferative population. Lineage tracing by retroviral
infection and 5-bromo-20-deoxyuridine (BrdU) labeling in vivo
have shown that NG2+ OPC divide locally and throughout the
adult rodent brain (Dawson et al., 2003; Kang et al., 2010). More-
over, using transgenic mice expressing tamoxifen-inducible
NG2creER and fluorescent Cre reporter alleles to study the
fate of single NG2 cells has revealed that age and neuroanatom-
ical location determine whether single NG2+ OPC can either self-
renew, generate mature oligodendrocytes, or do both (Zhu et al.,
2011).
NG2 potentiates the activity of growth factor receptors such as
platelet-derived growth factor receptor a (PDGFRa) and fibro-
blast growth factor receptor (FGFR) in part by enhancing ligand
binding (Goretzki et al., 1999). Numbers of proliferative OPC are
reduced temporarily in the cerebellum of adult NG2 knockout
mice, indicating that NG2 promotes OPC proliferation (Kuchar-
ova and Stallcup, 2010). NG2+ cells coexpress PDGFRa (Kang
et al., 2010) and PDGF signaling plays an instrumental role in
promoting OPC proliferation (Wolswijk and Noble, 1992).
Epidermal growth factor receptor (EGFR) segregates asymmet-
rically and is involved in cell fate choices in embryonic glial
progenitor cells (Sun et al., 2005) and in adult neural stem cells
(Ferron et al., 2010). The role of EGFR signaling in NG2+ OPC
is less established. EGFR enhances adult oligodendrogenesis
and myelination (Aguirre et al., 2007). Moreover, constitutive
EGFR signaling in NG2+ OPC prevents their differentiation and
leads to hyperplasia (Ivkovic et al., 2008).
Recent studies suggest that proper polarity and asymmetric
cell division are lost as normal progenitors progress into precan-
cerous and malignant cells. Asymmetry-defective Drosophila
neuroblasts acquire tumor-like growth in vivo and genomic insta-
bility in vitro (Caussinus and Gonzalez, 2005). In mammary stem
cells and cancer stem cells, the tumor suppressor p53 maintains
asymmetric cell divisions (Cicalese et al., 2009). In hematopoi-
etic precursors, oncogene expression disrupts cell polarity and
increases symmetric, self-renewing divisions through deregula-
tion of the cell fate determinant Numb (Ito et al., 2010; Wu
et al., 2007). Here, we investigate whether NG2+ OPC divide
asymmetrically via an interaction of NG2 with asymmetric
EGFR segregation andwhether losing asymmetric division asso-
ciates with the neoplastic transformation of OPC.CanRESULTS
NG2+ Cells from White Matter Tissue Are
Oligodendrocyte Progenitor Cells
First, we determined the optimal temporal and anatomical
factors for our analyses of NG2+ OPC divisions. At P60, single
NG2+ OPC have been shown to self-renew and generate differ-
entiating oligodendrocytes (Zhu et al., 2011). OPC are enriched
in white matter areas such as the corpus callosum (CC). We
therefore coimmunostained mouse brains from P60 wild-type
mice for NG2, phospho-Histone-3 (PH3), a mitotic marker, and
DAPI to stain nuclei (Figure 1A; data not shown). As judged by
overlapping signal for NG2 and PH3, we found that in the CC
8% of NG2+ OPC are in mitosis (Figure 1A; Figure S1B available
online). In contrast, only 0.5% of NG2+ OPC are mitotic in the
subventricular zone (SVZ), a large germinal area (Figures S1A
and S1B). Thus, the CC at P60 is suitable to study dividing OPC.
NG2 is also expressed by brain pericytes (Ozerdem et al.,
2001). To distinguish OPC from pericytes, coimmunostainings
were performed for NG2 and OPC markers, PDGFRa and
Olig2. These stainings showed that 94% of NG2+ cells in the
CC express PDGFRa, Olig2, or both (Figures 1B and 1D) and
are thus OPC. NG2+ OPC are known to differentiate further
whereby they lose NG2 expression and gain expression of the
immature oligodendrocyte antigen O4. To determine the overlap
of NG2+ and O4+ stages of OPC at P60, we costained mouse
brains and found that only 4% of NG2+ OPC in the CC coexpress
O4 (Figures 1C and 1D). Our observations suggest that the CC
NG2+ and O4+ OPC represent distinct stages consistent with
an earlier study showing that the O4+ and O4- OPC respond to
different mitogenic signals (Gard and Pfeiffer, 1990).
We tested next whether NG2+ cells preserve OPC marker
expression, self-renewal and differentiation along the oligoden-
drocyte lineage in vitro. FACS was used to isolate NG2+ OPC
from freshly dissociatedCC tissue. In addition,we isolated neural
stem cells from the subcallosal zone, a germinal zone adjacent to
the CC, expanded them in neurosphere cultures (Seri et al.,
2006), and used them as a replenishable source for NG2+ OPC
(Figure 1E). Staining with OPC markers PDGFRa and Olig2 re-
vealed that 95% of acutely isolated and neurosphere-derived
NG2+ cells express OPC markers (Figure 1F; Figures S1C–S1E).
Next, we tested whether purified NG2+ OPC, similar to purified
rat OPC, exhibit limited self-renewal (Temple and Raff, 1986).
Acutely isolated NG2+ OPC were kept under proliferative condi-
tions for 48 hr then incubated with BrdU for 2 hr. Using flow cy-
tometry we determined that 35% of the cells were NG2+BrdU+
and were thus proliferative OPC. If the NG2+ cells self-renew,
the percentage of NG2+BrdU+ cells should remain stable during
subsequent proliferation cycles. To test this, we repeated BrdU
labeling and flow cytometry and found that the percentage of
NG2+BrdU+ cells remained stable at 35%–40% for up to three
consecutive divisions. This indicates that the NG2+ OPC self-
renew for at least three divisions (Figure 1G), consistent with
a recent in vivo report (Simon et al., 2011). The total number of
NG2+ cells obtained from neurospheres and ex vivo was similar,
and it remained unchanged for a minimum of six passages,
further pointing toward a stable rate of self-renewal (Figure S1F).
To test whether NG2+ OPC also generate differentiating oligo-
dendrocytes in vitro, we took a fraction of NG2+ cells fromcer Cell 20, 328–340, September 13, 2011 ª2011 Elsevier Inc. 329
Figure 1. NG2+ Cells Divide in Corpus Callosum and Exhibit Limited
Self-Renewal and Oligodendrocyte Differentiation Ex Vivo
(A) Immunofluorescent costaining for NG2 and mitosis marker phospho-
histone3 (PH3) showing proliferating NG2+ cells in the corpus callosum (CC)
of wild-type P60 mice. Scale bar represents 10 mM.
(B) NG2+ cells coexpress OPC markers PDGFRa and Olig2. Scale bar repre-
sents 50 mM.
(C) Immunofluorescent costaining for NG2 (asterisks) and O4 expression
(white arrows). Scale bar represents 100 mM.
(D) Quantification of OPC marker expression of NG2+ cells in the adult CC.
NG2+ cells are PDGFRa/Olig2/NG2 triple-positive (Ra/Olig2/NG2; 65%);
Ra/NG2 (23%), NG2/Olig2 (8%), and NG2/O4 (4%) double-positive. Two
percent of NG2+ cells are OPC marker-negative.
(E) Schematic of a hemisphere of a coronal brain section. NG2+ cells were
acutely isolated from CC tissue and also obtained from subcallosal zone
(SCZ)-derived neurospheres. Scale bar represents 100 mM.
(F) Immunofluorescent staining for NG2, PDGFRa, and Olig2 on acutely
isolated NG2+ cells.
(G) BrdU was added to FACS sorted, acutely isolated NG2+ OPC cells after
they have grown in culture for 48 hr, and flow cytometry was used to determine
the percentage of NG2 and BrdU double-positive (NG2+BrdU+) cells.
(H) NG2+ cells from p1–p3 were immunostained for NG2 and O4 after 10 days
in differentiation medium. Scale bar represents 100 mM.
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330 Cancer Cell 20, 328–340, September 13, 2011 ª2011 Elsevier Ineach passage and subjected them to oligodendrocyte differenti-
ation medium. A quantification of NG2+ and O4+ cells after
10 days revealed that 25% of NG2+ OPC had differentiated
into O4+ cells and little overlap of NG2 and O4 expression was
detected (Figure 1H). The number of O4+ cells was stable for
a minimum of three passages (Figure 1I). These data led us to
conclude that NG2+ OPC retain their dual capacity to self-renew
and to generate differentiating progeny following isolation.
NG2 Exhibits Polarized Localization and Segregates
Asymmetrically
Next we tested whether NG2+ OPC undergo asymmetric divi-
sions. We adapted a pair assay (Shen et al., 2002) to visualize
and quantify asymmetric protein distribution in NG2+ OPC (Fig-
ure 2A). In brief, dissociated cells were plated at clonal densities.
After 12–18 hr, the cells that entered mitosis began to form cell
pairs. By performing immunofluorescence for OPC markers
and DNA, we identified cell pairs and determined whether OPC
markers unequally distributed between daughter cells, which
indicates asymmetric cell divisions. Surprisingly, NG2 localized
to a polarized crescent and segregated asymmetrically (Figures
2A and 2B). In contrast, we did not detect any asymmetrical
pattern of PDGFRa and Olig2 (Figures S2A and S2B). In both
acutely isolated and neurosphere-derived NG2+ cells, NG2
segregated asymmetrically in 40%–46% of cell pairs (Figures
2B, 2C and 2E and Figure S2C) and distributed symmetrically
and more diffusely in the remaining. Asymmetric segregation of
cell fate determinants in neural progenitors depends on an intact
actin cytoskeleton (Erben et al., 2008; Sun et al., 2005). To inves-
tigate whether similar cytoskeletal constraints are operative
in NG2+ cells, we incubated acutely isolated NG2+ cells with
latrunculin A, an inhibitor of actin polymerization. We found
that latrunculin A inhibited asymmetric segregation of NG2 (aka
NG2 asymmetry) (Figures 2D and 2E), which shows that NG2
segregates asymmetrically in an actin-dependent manner.
To define at which stage in the cell cycle NG2 acquires polar-
ized localization, we costained cell pairs for NG2 and g-tubulin,
a centrosomal marker (Figure 2F). We found patchy NG2 locali-
zation uniformly around the cortex in G1/S cells. In G2 cells,
centrosomes have duplicated and NG2 was restricted to one
half of the cell cortex. In M phase cells, the centrosomes have
moved to opposite poles and NG2 localized to a cortical cres-
cent on one pole. Costaining of NG2 and a-tubulin, a marker
for mitotic microtubules, was performed to observe NG2 locali-
zation during mitosis (Figure 2G). As expected, NG2 localized
to a crescent in prophase, as the mitotic spindle assembled.
NG2 crescents were overlying one spindle pole in metaphase.
In telophase, NG2 segregated exclusively to one daughter cell.
Asymmetric localization of NG2 in mitosis was further confirmed
in NG2+ PH3+ cells (Figure S2D). NG2 crescents were not de-
tected laterally to the metaphase spindle or on opposite poles.
This suggested that after the NG2 crescents formed, they re-
mained stable and segregated asymmetrically.
To determine whether NG2 asymmetry occurred in vivo, we in-
jectedwild-type P60micewith BrdU and analyzed brain sections
of injected mice by immunofluorescence for BrdU, NG2, and(I) Percentage of O4+ cells remained 23%–26% for three passages. Error bars
are +/ standard error of the mean (SEM). See also Figure S1.
c.
Figure 2. NG2 Shows Polarized Localization and Segregates Asymmetrically in OPC
(A) Schematic of pair assay. Single cells plated under proliferative conditions enter mitosis and form cell pairs, which are fixed and immunostained. Cell pairs in
which proteins partition to one daughter cell are considered asymmetrical.
(B) A representative, neurosphere-derived mitotic cell pair with NG2 asymmetry.
(C) A representative acutely isolated cell pair with NG2 asymmetry. Scale bar represents 10 mm.
(D) Cell pair treated with latrunculin A shows cytoplasmic (white arrow) rather then polarized NG2 localization. Scale bar represents 10 mm.
(E) Percentage of cell pairs with NG2 asymmetry after latrunculin A and DMSO (control) treatment. **p = 0.0087 by Student’s t test.
(F) Immunofluorescent costaining for NG2 and gamma (g)tubulin (gTub) to label centrosomes. 1 asterisk = 1 centrosome. White arrow points to patchy NG2
staining in G1/S phase. Scale bar represents 10 mm.
(G) Immunofluorescence costaining for NG2 and alpha (a)-tubulin (aTub) to label the mitotic spindle. Scale bar represents 10 mm.
(H) Representative cell pair in vivo with NG2 asymmetry after immunofluorescent costaining for NG2, BrdU, and PH3. P60 mice were injected with BrdU prior to
sacrifice. White arrows point to NG2+ cell in pair. Scale bar represents 10 mm.
(I) Percentage of cell pairs with NG2 asymmetry from acutely isolated cells (ex vivo) andCC tissue (in vivo). Error bars are +/SEM. (D), (F), and (G) were performed
with neurosphere-derived cells. See also Figure S2.
Cancer Cell
Asymmetry Defects in Glioma PrecursorsPH3.We frequently found twoBrdU+ cells in close vicinity to each
other in the CC and cortex, suggesting that these might be pairs.
CostainingwithPH3allowedus todistinguishbetween twoBrdU+
cells that incidentally localized next to each other from newly
generated cell pairs, i.e., those that underwent mitosis. NG2
distributed asymmetrically in 52% of BrdU+PH3+ cell pairs (Fig-
ures 2H and 2I; Figure S2E). These data show that NG2 segre-
gates asymmetrically in proliferating OPC in vivo and ex vivo.
OPC Divide Asymmetrically to Generate Cells
of Distinct Fate
Asymmetric cell divisions generate progeny of distinct fate. We
therefore tested whether NG2 asymmetry associated withCandistinct proliferative and differentiation capacities in the OPC
progeny. Acutely isolated NG2+ cells from wild-type mice were
kept under proliferative conditions to divide into NG2+ and
NG2 progeny for 48 hr. Subsequently, we added BrdU for
6 hr and quantified BrdU+ cells in relation to NG2 expression
by flow cytometry and in pair assays (Figure 3A). We found
that 78% of the NG2+ progeny but only 19% of the NG2
progeny had re-entered proliferation as determined by BrdU
incorporation (Figures 3B and 3C). Consistent with these data,
in pairs with NG2 asymmetry, 85% of the NG2+ and only 8% of
the NG2- progeny incorporated BrdU (Figures 3D and 3E). In
the remaining 7% of cell pairs with NG2 asymmetry BrdU was
weak or absent. When both daughter cells were NG2+, i.e.,cer Cell 20, 328–340, September 13, 2011 ª2011 Elsevier Inc. 331
Figure 3. OPC Undergo Asymmetric Cell
Division with NG2 Tracking Proliferative
Fate
(A) Schematic of experimental approach to
determine differences in proliferative cell fate.
Acutely isolated NG2+ OPC divide into NG2+ and
NG2 cells in proliferative medium for 48 hr (divi-
sion 1). Cells were then treated with BrdU to label
those reentering division within the next 12 hr
(division 2). BrdU+ cells in the NG2+ and NG2
progeny were quantified by flow cytometry (B and
C) and in pair assays (D and E).
(B) A representative flow cytometry plot showing
overlap between NG2 expression and BrdU
incorporation. Grey line indicates border set
between BrdU and BrdU+ cells.
(C) Percentage of BrdU+ cells in the NG2+ and
NG2 progeny.
(D) A representative cell pair with NG2 asymmetry
immunostained for NG2 and BrdU. Scale bar
represents 10 mM.
(E) Percentage of BrdU staining in cell pairs with
NG2 asymmetry.
(F) Schematic of experimental approach to deter-
mine differentiating fate. Freshly isolated OPC
kept under proliferative conditions for 48 hr (divi-
sion 1) were resorted into NG2+ and NG2 cells,
switched to differentiation medium (differentiation)
and percentage of O4 expression was assessed by flow cytometry 24 hr after sorting (G and H) and pair assays 48 hr after plating (I and J).
(G) A representative flow cytometry plot for O4 expression in the NG2 (left plot) and NG2+ (right plot) population.
(H) Percentage of O4+ cells as determined by flow cytometry.
(I) A representative cell pair with NG2 asymmetry and coimmunostained for O4 and NG2. Scale bar represents 10 mM.
(J) Percentage of O4 expression in cell pairs with NG2 asymmetry. Error bars are +/ SEM. See also Figure S3.
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shown). We concluded that the NG2+ progeny proliferates at
higher rates than the NG2 progeny of asymmetrically dividing
OPC. To determine the fate of the NG2 progeny, we sorted
NG2+ cells from freshly isolated CC tissue and separated the
NG2+ and NG2 progeny again by FACS and subjected them
to differentiation conditions (Figure 3F; Figure S3A). Flow cytom-
etry revealed 7%of NG2 progeny expressed O4+ within 24 hr of
differentiation. In contrast, only 1% of NG2+ progeny generated
O4+ cells (Figures 3G and 3H). Moreover, in pairs with NG2
asymmetry, 82% of the NG2 progeny and only 10% of the
NG2+ progeny acquired O4 expression after 48 hr in differentia-
tion medium (Figures 3I and 3J). In the remaining 8% of cell pairs
with NG2 asymmetry and in all cell pairs with symmetric NG2
distribution, O4 staining was weak or absent (not shown). More-
over, under prolonged differentiation conditions 32% of NG2
progeny remained O4+. In contrast, only 16% of NG2+ progeny
eventually acquired O4 expression (Figures S3B and S3C). We
concluded that NG2 asymmetry generates OPC progeny with
distinct proliferative and differentiation capacities (Figure S3D).
NG2 tracks proliferation and biases cells toward self-renewal.
In contrast, NG2 progeny of asymmetrically dividing OPC
acquire differentiating fate.
NG2 Promotes Asymmetric EGFR Localization
and EGF-Dependent Responses
To get mechanistic insights into asymmetric OPC divisions, we
tested whether EGFR, which regulates OPC proliferation, segre-
gates asymmetrically in OPC. Indeed, EGFR localized to a polar-332 Cancer Cell 20, 328–340, September 13, 2011 ª2011 Elsevier Inized crescent and segregated asymmetrically in mitotic cell pairs
(Figure 4A). In acutely isolated and neurosphere-derived cells,
NG2 and EGFR colocalized and cosegregated in 82% of cell
pairs with NG2 asymmetry (Figure 4B; Figure S4A). EGFR auto-
phosphorylation is associated with its ligand-induced activation
(Bae and Schlessinger, 2010). To determine whether asymmetri-
cally segregated EGFR is active, we costained cell pairs for
NG2 and phospho-EGFR (p-EGFR) using an antibody directed
against the phosphorylated autophosphorylation site tyrosine
1068. We found that the majority of the NG2+ progeny (>60%),
but rarely the NG2 progeny, stained for p-EGFR (Figures 4C).
Taken together, these data show that EGFR localizes asymmet-
rically to and is activated in the self-renewing NG2+ OPC but not
the differentiating NG2 progeny.
To distinguish between an active and passive role of NG2
in asymmetric OPC divisions, we analyzed NG2 knockout
(NG2KO) OPC for EGFR asymmetry and EGF-dependent re-
sponses (Grako et al., 1999). We used PDGFRa as a surface
marker for acute isolation of OPC from the CC of adult, viable
NG2KOmice and NG2 wild-type (NG2WT) littermates. We found
that EGFR distributed asymmetrically in only 16% of cell
pairs from NG2KO OPC compared to 82% from NG2WT OPC
(Figures 4D and 4E; Figure S4B). Moreover, p-EGFR localized
asymmetrically with reduced overall intensity of staining in only
6% of NG2KO OPC (Figures 4F and 4G). In addition, inhibitory
NG2 antibodies blocked EGFR asymmetry and increased
symmetrical EGFR distribution in otherwise wild-type OPC
(Figures S4C and S4D). Some activated neural stem cells and
transit-amplifying cells isolated as CD15+ cells from NG2KOc.
Figure 4. NG2 Regulates EGFR Asymmetry and EGF-Dependent Proliferation and Self-Renewal
(A) Immunofluorescent costaining for EGFR and a-tubulin of neurosphere-derived cells at distinct stages of mitosis.
(B) A representative NG2+ OPC cell pair coimmunostained for NG2 and EGFR (white arrows).
(C) A representative NG2+ OPC cell pair coimmunostained for NG2 and p-EGFR (white arrow). EGF is present in medium. Scale bar represents 10 mM.
(D) A representative NG2KO OPC cell pair coimmunostained for PDGFRa+ (Ra) and EGFR showing symmetric EGFR. Scale bar represents 10 mM.
(E) Percentage of cell pairs with asymmetric (asym) and symmetric (sym) EGFR.
(F) A representative NG2KOOPCcell pair coimmunostained for PDGFRa+ (Ra) and p-EGFR showing symmetric, faint p-EGFR signal. Scale bar represents 10 mM.
(G) Percentage of cell pairs with asymmetric p-EGFR staining.
(H) EGF-starved neurosphere cells were treated with EGF for 48 hr and cell numbers were determined.
(I) Percentage of PDGFRa and BrdU double positive (Ra+BrdU+) cells with (w/ EGF) and without (w/o EGF) EGF.
(J) Percentage of PDGFRa and PH3 double-positive (Ra+PH3+) cells. OPCwere acutely isolated from the CC of P60 NG2WT and NG2KOmice using PDGFRa as
selectionmarker with the exception of (A) and (H). There, OPCwere isolated from low passage subcallosal zone-derivedNG2WT andNG2KO neurospheres. Error
bars are +/ SEM. **Students t test p < 0.01. *Student’s t test p < 0.05. See also Figure S4.
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p-EGFR staining (Figure S4E). This suggests that the effect of
NG2 loss on EGFR signaling is specific for NG2+ OPC. To inves-
tigate the mechanism by which NG2 might regulate EGFR
signaling, we tested EGF ligand binding to NG2KO and
NG2WT cells. We found that fluorescent EGF ligand (EGF-488)
bound preferentially to the NG2+ progeny of cell pairs with
NG2 asymmetry (Figure S4F). EGF still bound, albeit symmetri-
cally, to cell pairs of NG2KO OPC, indicating that NG2 is not
essential for EGF binding (Figures S4G and S4H). These data
show that NG2 is required for asymmetric distribution of EGFR
to the NG2+ progeny. Consequently, EGFR is activated in the
NG2+ but not the NG2 progeny.
We tested next whether NG2 is required for EGF-dependent
OPC responses. NG2KO and NG2WT subcallosal neurospheres
were EGF-depleted and subsequently treated with EGF for 48 hr.
FACS sorted PDGFRa+ OPC were quantified for their prolifera-
tive response with a proliferation assay. Following EGF treat-
ment, we detected a 30% cell number increase in NG2WT
cultures and only a 5% increase in NG2KO cultures (Figure 4H).
Moreover, pretreatment of neurospheres with inhibitory NG2
antibodies but not with IgG control decreased the proliferation
rate of OPC (Figure S4I).CanTo assess EGF-dependent self-renewal, PDGFRa+ OPC were
acutely isolated from NG2KO and NG2WT mice and grown
without EGF. Subsequently, half of the cells were stimulated
with EGF. BrdU was added and PDGFRa+BrdU+ cells were
quantified over three passages by flow cytometry, as before (Fig-
ure 1G). NG2WT PDGFRa+BrdU+ cells increased from 18%
without EGF to 38% in response to EGF treatment. In contrast,
we detected only 16% of NG2KO PDGFRa+BrdU+ cells with
EGF and 14% in the absence of EGF (Figure 4I). The lack of
EGF-induced proliferation is specific for NG2KO OPC, as self-
renewal of CD15+ cells in NG2KO neurospheres was unaffected
(Figure S4J). Moreover, BrdU+NG2+ cells were reduced
following treatment with inhibitory NG2 antibodies (Figure S4K).
These data show that NG2 is required for EGF-dependent prolif-
eration and self-renewal of OPC.
To test whether loss of NG2 would also result in decreased
OPC proliferation in vivo, we counted the PDGFRa+PH3+ cells
in the CC. In line with an earlier analysis (Kucharova and Stallcup,
2010), we found a small but significant reduction of proliferating
OPC in the CC of NG2KO mice at P60 compared to NG2WT
littermates (Figure 4J). These data showed that NG2 is required
for asymmetric segregation of EGFR and EGF-dependent OPC
proliferation and self-renewal.cer Cell 20, 328–340, September 13, 2011 ª2011 Elsevier Inc. 333
Figure 5. Asymmetric OPC Divisions Are Decreased in a Mouse Glioma Model
(A) A p53+/ OPC cell pair is stained for NG2 and EGFR. Scale bar represents 10 mM.
(B) A verbB p53+/ OPC cell pair is stained for NG2 and EGFR. Scale bar represents 10 mM.
(C) Percentage of NG2 and EGFR asymmetry in control and verbB p53+/ OPC following their acute isolation from CC tissue.
(D) An OPC cell pair in the CC of verbB p53+/ mice is stained for NG2, PH3, and BrdU. Scale bar represents 50 mM.
(E) Percentages of NG2 asymmetry are 23% in acutely isolated (ex vivo) verbB p53+/ cells and 13% in verbB p53+/ tissue (in vivo), compared to 41% in acutely
isolated control, p53+/ OPC, and 42% in control, p53+/ CC tissue.
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Cancer Cell
Asymmetry Defects in Glioma PrecursorsDecreased Asymmetric Divisions Correlate with
Increased Self-Renewal at the Expense
of Differentiation
The mechanism for neoplastic transformation of NG2+ OPC is ill
defined. NG2+ OPC give rise to endogenous, oligodendro-
glioma-like tumors in transgenic S100b-verbB mice, which
constitutively activate EGFR signaling at early postnatal stages
(Persson et al., 2010; Weiss et al., 2003). S100b-verbB mice
with hemizygous deletion of the tumor suppressor p53 succumb
to tumors after a 4–6 month latency period. Homozygous loss of
p53 shortened the latency period (Figure S5A). To investigate
early changes, we isolated NG2+ cells acutely from the CC of
S100b-verbB p53+/ (verbB p53+/ OPC) during the latency
period at P60 and from control, p53+/ littermates. In pair assays,
NG2 and EGFR segregated asymmetrically in only 22% of verbB
p53+/ OPC compared to 41% of control OPC (Figures 5A–5C).
In the remaining 78% of verbB p53+/ OPC, NG2 distributed
symmetrically. In addition, asymmetric cell division rates de-
creased in verbB p53+/ NG2+ cell pairs from subcallosal
neurospheres and from verbB p53+/ mice in vivo (Figures 5D
and 5E; Figures S5B–S5D). Noteworthy, homozygous loss of
p53 decreased asymmetric cell division rates of NG2+ cells
from subcallosal neurospheres (p53/: 32%; p53+/+: 46%; p =
0.079) (Figure S5D).
We tested next whether lower rates of asymmetric cell division
and concurrent increases in symmetric cell division coincide
specifically with aberrant self-renewal and impaired differentia-
tion of OPC.We found that self-renewal was increased in acutely
isolated verbB p53+/ NG2+ OPC compared to control OPC
(Figure 5F). In contrast, the self-renewal of CD15+ adult neural
stem cells and transit amplifying cells was unchanged in verbB
p53+/ neurospheres (Figure S5E). Overall numbers of OPC
were also increased in verbB p53+/CC tissue to 14%compared
to 9% in control tissue (Figure 5G; Figures S5F and S5G). Under
differentiation conditions, verbB p53+/ NG2+ OPC retained
NG2 and Olig2 expression at higher rates and generated only
3% O4+ cells compared to 25% generated by control OPC
(Figures 5H–5J; Figures S5H–S5M). Taken together, these data
showed that at premalignant stages OPC exhibit reduced rates
of asymmetric divisions accompanied by increased symmetric
divisions, aberrant self-renewal and impaired oligodendrocyte
differentiation.
Asymmetry-Defective OPC Have Tumor-Initiating
Potential
To investigate the possibility that latent verbB p53+/ OPC are
glioma precursors, we evaluated their tumor-initiating potential.
NG2+ cells were isolated by FACS from early-passage subcal-
losal neurospheres of verbB p53+/ latent and p53+/ control
P60 mice and from endogenous tumors, which have been re-(F) Percentage of NG2+BrdU+ cells in verbB p53+/OPC and control cells as deter
passage 1 (p1) and passage 3 (p3), respectively, are NG2+BrdU+. Scale bar repr
(G) OPC numbers, as determined by quantifying triple-positive (NG2/Ra/Olig2) c
(H and I) Control and (I) verbB p53+/ OPC plated for differentiation and stained
(J) Percentage of NG2+ cells differentiated into O4+ cells 10 d after differentiat
In contrast, verbB p53+/O4+ cells with overlapping NG2 staining (yellow staining
Pair assays (A and B), self-renewal (F), and differentiation (H and I) experiments
are +/ SEM. **Student’s t test p < 0.01. See also Figure S5.
Canported to develop spontaneously in S100b-verbB p53/ mice
(Weiss et al., 2003). Cells were injected orthotopically into adult
mice, which were monitored for symptoms. Within 5–6 months,
mice injected with verbB p53+/ NG2+ cells isolated from the
latent stage consistently developed symptoms indicative of
tumor growth, whereas mice injected with p53+/ cells remained
asymptomatic. NG2+ tumor-derived cells developed tumors
within 2–3 months (Figure 6A). Hematoxylin and eosin staining
of fixed brain sections from symptomatic mice revealed massive
tumors in the prefrontal cortex, which infiltrated the brain paren-
chyma, exhibited high cellularity, and had a ‘‘fried egg’’ cellular
appearance typical of oligodendroglial tumors (Figures 6B and
6C). Immunofluorescence staining revealed that the majority of
cells within the tumor mass expressed the OPC markers NG2
and Olig2 and only a small number expressed astrocytic and
neuronal markers GFAP and Nestin (Figures 6D and 6E). Immu-
nohistopathological analyses further confirmed that orthotopic
tumors share characteristics of grade II-III oligodendrogliomas
with endogenous tumors in S100b-verbB p53/ mice (Figures
S6A–S6H).
Immunofluorescence of tumor tissue detected predominantly
symmetric NG2 in mitotic cells (Figure 6F). Pair assays of NG2+
cells derived from either orthotopic or endogenous tumors
showed that in tumor-derived cells NG2 asymmetry is reduced
further compared to that in verbB p53+/ cells from the latent
state (Figure 6G). NG2+ cells from orthotopic tumors can be
serially re-transplanted, indicative of self-renewal. Under differ-
entiating conditions in vitro, NG2+ tumor-derived cells failed
to differentiate into mature oligodendrocytes (Figure S6I). We
concluded that verbB p53+/NG2+ OPC isolated at latent stages
are glioma precursors.
In Human Oligodendrogliomas, NG2+ Cells Lose
Asymmetric Divisions and Asymmetry Regulators
Are Misexpressed
HowNG2+ OPC relate to NG2+ tumor-initiating cells from human
oligodendrogliomas is not well understood. To test whether
NG2+ cells from human oligodendrogliomas—similar to NG2+
glioma precursors—show abnormal asymmetric cell division
rates, we isolated NG2+ cells by magnetic activated cell sorting
from surgical specimens from grade II and grade III oligodendro-
gliomas. NG2+ cells isolated from the temporal lobes of epilepsy
patients were used as non-neoplastic controls (Figure 7A). In pair
assays, the rates of asymmetric NG2 and EGFR segregation in
tumor-derived NG2+ cells were reduced to 8%–48% (Figures
7B and 7C). In contrast NG2 and EGFR segregated asymmetri-
cally in 75%–78% of non-neoplastic human NG2+ cells (Figures
7B and 7D). We tested next whether loss of NG2 and EGFR
asymmetry associates with particular genetic alterations
frequently found in oligodendrogliomas. We confirmed that allmined by flow cytometry. Forty-seven percent and 76%of verbB p53+/ cells at
esents 100 mM.
ells, in the verbB p53+/ and the control CC tissues.
for NG2 and O4.
ion. O4 staining nonoverlapping with NG2 in control cells (white arrow in H).
; white arrow in I). O4 and NG2 double-positive cells were counted as O4+ cells.
were done with acutely isolated NG2+ cells. Controls are p53+/. Error bars
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Figure 6. Asymmetry-Defective OPC Initiate Orthotopic Tumors
(A) Kaplan-Meier survival curves of mice injected with 100,000 p53+/, verb
p53+/, and tumor-derived NG2+ cells.
(B and C) Hematoxylin and eosin staining of orthotopic tumors from verb
p53+/ NG2+ cells. The white arrow in (B) indicates infiltrative tumor cells and
the white arrow in (C) indicates a cell with the ‘‘fried egg’’ appearance, a feature
typical for oligodendroglial tumors. Scale bar represents (B) 100 mM; (C)
200 mM.
(D and E) Immunofluorescent staining of orthotopic tumors for NG2 and GFAP
(D) and for Olig2 and Nestin (E). Scale bar represents 100 mM.
(F) NG2 staining of orthotopic tumor at higher magnification. The white arrow
points to a mitotic cell pair identified by nuclear staining with symmetric NG2.
Scale bar represents 10 mM.
(G) Percentage of cell pairs with symmetric (white area) and asymmetric (black
area) NG2. NG2 asymmetry is 23% in acutely isolated verbB p53+/ cells and
is 18% in cells isolated from orthotopic (tumor/o) and 10% in cells isolated
from endogenous tumors (tumor/e). Error bars are +/ SEM. Student’s t test,
*p < 0.05. See also Figure S6.
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Asymmetry Defects in Glioma Precursorsoligodendrogliomas have combined allelic loss of chromosomal
arms 1p and 19q (1p19q codeleted) (Jenkins et al., 2006). EGFR
amplifications portend progression to high-grade disease and
recurrence in oligodendrogliomas (Ducray et al., 2008). Indeed,
aneuploidy and high EGFR score were documented in the recur-
rent grade II and the grade III tumors. NG2 asymmetry was not
consistently decreased further in tumors with increased tumor
grade, recurrence, or high EGFR scores (Figure 7B).336 Cancer Cell 20, 328–340, September 13, 2011 ª2011 Elsevier InMoreover, database analyses found asymmetric cell division
regulators to be misexpressed in low-grade oligodendrogliomas
(Figure 7E). Changes were investigated in the expression level of
29 genes encoding candidate asymmetry regulators in expres-
sion profiles of 27 human grade II oligodendroglioma samples
and 28 reference samples from the Repository for Molecular
Brain Neoplasia Data (Table S1) (Madhavan et al., 2009). Signif-
icant differential expression between the two groups at p < 0.05
was identified for 15 genes, nine of which were upregulated
and six of which were downregulated in tumors (Table S1 and
Figure S7). Taken together, decreased rates of asymmetric cell
divisions occur in low- and high-grade oligodendroglioma
NG2+ cells and correlate with 1p19q codeletion and misexpres-
sion of regulators of asymmetric cell division.
DISCUSSION
Polarized Distribution and Asymmetrical Segregation
of NG2 in Postnatal OPC
By showing that NG2 segregates asymmetrically and is part of
a cell fate switch in OPC, we provided evidence that OPC
undergo asymmetric divisions to establish tissue homeostasis
in the adult brain. Because culturing conditions alter the expres-
sion of OPC markers (Dromard et al., 2007; Gabay et al., 2003),
we have used acutely isolated cells whenever possible. In addi-
tion, we showed that NG2+ OPC undergo symmetric divisions in
the CC. In areas adjacent to the SVZ, NG2+ cell pairs with exclu-
sively symmetric NG2 distribution have been found (Ge et al.,
2009). Differences in the length of BrdU treatment and temporal
factors may explain why the recent study reported only symmet-
rically dividing NG2+ OPC. NG2 cells have an extended G1 cycle
(Simon et al., 2011) and the NG2+ cell cycle slows down with age
in the rodent brain (Psachoulia et al., 2009), suggesting that
short BrdU treatment might miss some NG2+ cells. Moreover,
cell fate analyses of NG2+ cells suggest that asymmetric cell
divisions occur only at later postnatal stages in mice (Zhu
et al., 2011). Why both asymmetric and symmetric division
modes exist at P60 is unknown. The NG2+ OPC cells expand
rapidly after stab wounding (Simon et al., 2011) and they
generate new oligodendrocytes after toxin-induced demyelin-
ation (Zawadzka et al., 2010). It is attractive to speculate that
although asymmetric cell divisions maintain tissue homeostasis
in the healthy, adult brain, symmetrically dividing OPC rapidly
expand in the injured brain.
Regulation of NG2 Asymmetry
The majority of Drosophila asymmetry regulators are conserved
in mammals (Knoblich, 2010). In Drosophila these proteins work
together in conjunction with an intact actin cytoskeleton to
distribute cell fate determinants unequally between daughter
cells (Petritsch et al., 2003). The present study shows that an
intact actin cytoskeleton is also required for asymmetric segre-
gation of NG2, which indirectly suggests that the mechanism
for asymmetric NG2 localization might be conserved in
mammalian OPC. Reversible phosphorylation by several
kinases plays an important role in establishing cell polarity
and asymmetric cell division in Drosophila neuroblasts. NG2
is a transmembrane protein with a large extracellular and a small
cytoplasmic domain (Trotter et al., 2010). Noteworthy, twoc.
Figure 7. Human Oligodendrogliomas Have NG2+ Cells with Reduced Asymmetric Cell Division andMisexpress Genes Encoding Conserved
Asymmetry Regulators
(A) Summary of human oligodendrogliomas used in the study.
(B) NG2+ cells were acutely isolated from surgically removed tumor and non-neoplastic brain tissue specimens and percentage of cell pairs with NG2 asymmetry
is determined using pair assay. Error bars are +/ SEM.
(C and D) Representative NG2+ cell pairs from tumor (C) and non-neoplastic tissue (D) stained for NG2 and EGFR. Scale bars represent 10 mM.
(E) Box plots representing changes in gene expression levels at a p < 0.05 of seven conserved, candidate asymmetry regulator genes in control brain tissue (NT)
versus low-grade oligodendroglioma tissue (ODGII). The band in each box represents the median and the bottom and top the 25 and 75 percentile, respectively.
The errors bars are the minimum and maximum of data. See also Table S1 and Figure S7.
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Asymmetry Defects in Glioma Precursorsdistinct phosphorylation events within the small cytoplasmic
domain of NG2 regulate dynamic redistribution and differential
function of NG2 in human astrocytoma cells (Makagiansar
et al., 2007). It will be interesting to determine whether differen-
tial phosphorylation of NG2 regulates its asymmetric pattern
in OPC.
OPC Asymmetry and Self-Renewing Cell Fate
Our data suggest that NG2 and EGFR provide a cell fate switch,
which instructs the OPC progeny to proliferate and self-renew in
response to activated EGFR signaling rather then to differentiate.
Indeed, reduced signaling of EGFR in wa1 mice leads to attenu-
ation of NG2+ OPC proliferation under normal physiological
conditions and after focal demyelination (Aguirre and Gallo,
2007). NG2 might establish EGFR asymmetry directly, e.g., byCanaffecting EGFR degradation or by inducing conformational
changes in EGFR that facilitate asymmetric segregation and
hence activation in only one of the two daughter cells. EGFR
asymmetry in neural stem cells in the adult SVZ is regulated by
endocytosis-mediated degradation via dual-specificity kinase
Dyrk1A (Ferron et al., 2010). EGFR expression levels are, how-
ever, not visibly changed in NG2KO OPC, suggesting that
EGFR stability is not regulated by NG2. Proteoglycans have
been reported to function as coreceptors and facilitate confor-
mational changes (Ruoslahti and Yamaguchi, 1991). It remains
to be determined whether EGFR conformation and its activation
in the NG2+ daughter cells may depend on NG2. Further investi-
gations are needed to study the alternative possibility that NG2
regulates EGFR activation indirectly by interacting with other
proteins.cer Cell 20, 328–340, September 13, 2011 ª2011 Elsevier Inc. 337
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The notion that asymmetric cell divisions protect stem and
progenitor cells from neoplastic transformation has been indi-
rectly supported by data in leukemia (Congdon and Reya,
2008) and mammary cancer (Cicalese et al., 2009). Our data
point toward a direct lineage relationship of asymmetry-defec-
tive NG2+ OPC—the glioma precursors—and NG2+ tumor initi-
ating cells from low- and high-grade oligodendrogliomas (Pers-
son et al., 2010). Importantly, conserved regulators of polarity
and asymmetric cell division are bona fide oncogenes and tumor
suppressors (Knoblich, 2010). Only a few of the conserved
asymmetry regulators have established functions in regulating
cell fate, self-renewal, and differentiation in mammalian neural
progenitors. Among those are Trim32, a homolog of the transla-
tional regulator and cell fate determinant Brat (Schwamborn
et al., 2009), and Pard3, a PDZ-domain protein (Bultje et al.,
2009). Both proteins localize asymmetrically in neural progenitor
cells and control the balance of self-renewal and differentiating
neurons. Importantly, we found trim32 and pard3 among
those genes, which are significantly misexpressed in grade II
oligodendroglioma tissue. In addition, downregulated in grade
II oligodendroglioma tissue is trim3, which encodes Trim-NHL
proteins and homologs of the brat/mei-26 tumor suppressors
(Lee et al., 2006). Moreover, atypical protein kinase C zeta
(pkcz), the G protein signaling modulator and ags3-like gene
gpsm3, and the cell fate determinant numblike (numbl) are
also downregulated in grade II oligodendrogliomas, albeit at
p > 0.05. pkcz and gpsm3 map to chromosome 1p and numbl
maps to chromosome arm 19q. 1p and 19q are frequently code-
leted in low-grade oligodendrogliomas. Future studies will be
aimed at investigating asymmetry regulator functions in glioma
precursors. Defects in asymmetric cell division may provide




All mouse experiments were approved by and performed according to the
guidelines of the Institutional Animal Care and Use Committee of the University
of California, San Francisco. S100b-verbB transgenic and p53 null alleles were
maintained in a pure FvB/N background, bred and genotyped as previously
described (Weiss et al., 2003). Mice homozygous deleted for NG2 and control
littermates were maintained on a C57/B6 background as described (Kuchar-
ova and Stallcup, 2010). NOD SCID mice were from Jackson Laboratories.
Cell Culture and Pair Assay
Cells were isolated from the CC that includes the subcallosal zone of 2-month-
old mice unless otherwise stated, cultured in neurosphere proliferative
medium with EGF and bFGF as previously described. Cells were subjected
to a pair assay as described (Sun et al., 2005). In brief, cells were plated at
clonal density for 12–36 hr and cell pairs formed were observed and fixed
and subjected to immunostaining with primary antibody and fluorescence-
coupled secondary antibody as previously described. Nuclei were visualized
using DAPI (Sigma). Unless indicated otherwise, for pair assay a minimum of
50 and up to 200 cell pairs per cell type and condition, respectively, were
analyzed, using a fluorescent microscope.
Immunostaining and In Vivo Pair Assay
Mouse sections were made from fresh frozen brains, postfixed for 10 min with
4% PFA, blocked with PBS 10% NGS, 0.1% Triton X-100 for 1 hr and stained
with primary antibody o/n, washed and stained with fluorescence-couple338 Cancer Cell 20, 328–340, September 13, 2011 ª2011 Elsevier Insecondary antibodies. For BrdU labeling, mice were injected intraperitoneally
with 10 mg/ml BrdU every 12 hr for 3 days, brains were sectioned and post-
fixed with acetone/methanol (1:1) for 5 min. For quantification of cell pairs,
the entire CC area was counted for cells expressing OPC markers and PH3/
BrdU/NG2 triple-positive cells and a minimum of three distinct brain sections
was counted per animal in three individual animals. Antibodies used are
described in Supplemental Information.
Human Oligodendroglioma
The Brain Tumor Research Center Tissue Bank (University of California, San
Francisco) provided the human tumor samples. The samples were collected
during surgery from consented patients, assigned a nonidentifying number
(SF#) according to protocol approved by the UCSF Committee on Human
Research, stored in proliferative neurosphere medium at 4C, processed
within four hours after resection and NG2+ cells were isolated as described
using NG2 antibody (1:500; Chemicon) andmicrobead-tagged goat anti-rabbit
IgG (Miltenyi) (Persson et al., 2010).
Gene Expression Analysis of Asymmetric Cell Division Regulators
The expression profiles for 27 human ODG grade II tumor samples and 28
reference samples were downloaded from the REMBRANDT database. The
null hypothesis H0 that tumor samples and normal brain samples exhibit no
differences in expression was tested against its alternative H1 for every asym-
metry gene available in the data set. A Mann-Whitney test was performed for
candidate asymmetry genes and adjusted for multiple hypotheses testing
using the FDR correction. Differential expression between the two groups
was identified for 15 genes at a p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and one table and can be
found with this article online at doi:10.1016/j.ccr.2011.08.011.
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